✦ LIBER ✦

2.2 The binding of mouse-anti-human IL-2 receptor antibody and rIL-2 to Xenopus immunocytes: Artifact or molecular conservation?

✍ Scribed by L.N. Ruben; Lorene Langeberg; Rachel Lee; R.H. Clothier; A. Malley; M. Balls

Book ID: 119076911
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 74 KB
Volume: 13
Category: Article
ISSN: 0145-305X
DOI: 10.1016/0145-305x(89)90058-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The characterization of the toad splenoc

The characterization of the toad splenocytes which bind mouse anti-human IL-2 receptor antibody

✍ Lorene Langeberg; Laurens N. Ruben; Richard H. Clothier; Stanley Shiigi 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Blocking of interleukin 2 (IL 2) binding

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18

✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been

Specific binding and lysis of human mela

Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: A possible approach to the immunotherapy of human tumors

✍ Michael T. Lotze; Kevan Roberts; Mary C. Custer; David A. Segal; Steven A. Rosen 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 892 KB

Nonapeptide corresponding to the sequenc

Nonapeptide corresponding to the sequence 27–35 of the mature human IL-2 efficiently competes with rIL-2 for binding to thymocyte receptors: V.P. Zav'yalov, E.V. Navolotskaya, I.S. Isaev, O.A. Kaurov, A.A. Kobolov, R.N. Vasilenko, V.G. Galaktionov and A.I. Denesyuk

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A phase I pharmacokinetic (PK) and seria

A phase I pharmacokinetic (PK) and serial tumor and skin pharmacodynamic (PD) study of weekly, every 2 weeks or every 3 weeks 1-hour (h) infusion EMD72000, an humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients (p) with advanced tumors known to overexpress the EGFR

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB